Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
about
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's DiseaseApolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer diseaseFunctions of the cellular prion protein, the end of Moore's law, and Ockham's razor theoryBrain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrP(C)), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum diffFrom high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys.Evolutionary implications of metal binding features in different species' prion protein: an inorganic point of view.Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9.Plasma prion protein concentration and progression of Alzheimer disease.A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob diseaseTau, prions and Aβ: the triad of neurodegeneration.Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.CSF prion protein concentration and cognition in patients with Alzheimer diseaseBasic mechanisms of neurodegeneration: a critical update.The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling ModulesInteraction between pathogenic proteins in neurodegenerative disorders.Role of statins in Alzheimer's disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs.Targeting Fyn Kinase in Alzheimer's Disease.The Role of Shed PrPc in the Neuropathogenesis of HIV Infection.Is AD a homogeneous nosologic entity? Yes.Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis.The Aβ peptides-activated calcium-sensing receptor stimulates the production and secretion of vascular endothelial growth factor-A by normoxic adult human cortical astrocytes.Alzheimer's disease: analysis of a mathematical model incorporating the role of prions.Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease.
P2860
Q26747527-8946C78E-10BC-4F07-B20B-A1B7284F3914Q26858870-40E190A6-6E17-4F73-A495-77263734B028Q28597985-3945C42C-FAD9-4AC9-BFDE-F249AAC8FCB0Q30416813-E3A80309-B561-4291-BF3A-B688503B1945Q31023317-E84959EC-FD4D-446C-92AF-FCEE9FE627E1Q31026808-4507ADA0-0386-48F4-A8B9-F78D4CFE9302Q33761828-01AA6167-7A2E-4B38-B84C-74ED36999B1BQ33912630-5089B7E9-EA39-48FC-94F4-5FAB89B1E358Q34046721-262339C2-4FAA-4BF4-992C-4175C4A7BEFAQ34307247-EEB82240-9251-4BCF-844C-96EB8052C87DQ34405864-DE9A64BA-F4F3-4811-9E86-A154CD959E7AQ34463061-E1C9A7A9-7E54-4118-9655-8851FD37CFD3Q34661859-9FFE8AA5-8893-4BF4-9E6B-032965BD29FBQ34733689-A97892A4-BE8C-4F20-B653-EAB31B8A8172Q35763065-1B97DC18-0499-40FA-9FCE-50119F3227C9Q36286065-0EB520A9-D57F-411D-BEA3-9420C845DBC4Q37197675-5090C1E7-70CC-497A-8A50-A36AC9D06D87Q37673274-1144EA03-7BE5-4BDD-8CDE-158761ADD4FEQ37710410-728257B2-4E65-4A79-A343-9CB8246D1733Q37969262-3AA6CF9B-B41E-4704-BF8C-77D43EBAD696Q38084372-B9C1DFCC-D3EF-432E-9C6D-FC4062DACACBQ38678555-7E7EC601-8160-4E27-90F6-F9C5A8B59CD8Q38769928-919350E6-B6B0-4E96-9ED8-66A872F120F7Q39390476-AE35F37F-BF92-4797-B343-D19E92591429Q41856782-3AD0EC7C-6E73-4293-867F-9890E51FC05DQ42218999-89E32F6E-CBCA-4E77-831C-DFDE04A97DE9Q48631163-C955610C-0415-4566-9FB0-F177FC3252C2Q48706261-BEE5ACFF-8CB8-4FCC-B0BF-3F4FC75F66FEQ50876344-794576DA-59A7-4715-8A77-C57DA8918CC9Q55436167-178FF190-D5EE-49B2-95E4-0862A5DD27DC
P2860
Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cellular prion protein mediate ...... cations for Alzheimer disease.
@ast
Cellular prion protein mediate ...... cations for Alzheimer disease.
@en
type
label
Cellular prion protein mediate ...... cations for Alzheimer disease.
@ast
Cellular prion protein mediate ...... cations for Alzheimer disease.
@en
prefLabel
Cellular prion protein mediate ...... cations for Alzheimer disease.
@ast
Cellular prion protein mediate ...... cations for Alzheimer disease.
@en
P2860
P1433
P1476
Cellular prion protein mediate ...... cations for Alzheimer disease.
@en
P2093
Haakon B Nygaard
P2860
P304
P356
10.1001/ARCHNEUROL.2009.223
P577
2009-11-01T00:00:00Z